Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
-$118,990 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
9 quarters on record
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Derivatives in ACLX
reported options exposure · as of Mar 31, 2026CallValue
$25,834,500
CallShares
225,000
PutValue
$2,870,500
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $196,103,961 across 70 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
420,143 | $14,066,387 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
274,116 | $10,887,887 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 |
All Filings in ACLX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,834,500 | 225,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $2,870,500 | 25,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $118,990 | 1,825 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $16,300,000 | 250,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $3,260,000 | 50,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $1,034,460 | 12,600 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $4,926,000 | 60,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $8,797,560 | 133,600 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $23,706,000 | 360,000 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $1,761,882 | 26,756 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,399,726 | 67,069 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $18,079,360 | 275,600 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $7,950,720 | 121,200 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $8,052,450 | 105,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $20,598,934 | 268,600 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $18,013,107 | 215,700 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $43,391,796 | 519,600 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $3,138,305 | 37,580 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $1,387,500 | 25,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $1,387,500 | 25,000 | Put | Sole | 2024-02-14 | |
| 2023-03-31 | $385,125 | 12,500 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $385,125 | 12,500 | Put | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||